MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$96,207,000
EPS
-$1.03
Unit: Dollar
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
License revenue
-
-
-
0
Research and development
77,889,000
70,112,000
63,497,000
39,617,000
General and administrative
32,235,000
31,759,000
39,061,000
22,412,000
Total operating expenses
110,124,000
101,871,000
102,558,000
62,029,000
Loss from operations
-110,124,000
-101,871,000
-102,558,000
-62,029,000
Interest income
14,591,000
13,289,000
12,901,000
2,110,000
Other expense, net
-93,000
-11,000
-314,000
-68,000
Total other income, net
14,498,000
13,278,000
12,587,000
2,042,000
Loss before income taxes
-95,626,000
-88,593,000
-89,971,000
-59,987,000
Income tax expense
581,000
260,000
239,000
358,000
Net loss
-96,207,000
-88,853,000
-90,210,000
-60,345,000
Unrealized gain (loss) on available-for-sale securities, net of tax
-
-235,000
671,000
-320,000
Foreign exchange translation adjustment, net of tax
-
-25,000
132,000
-164,000
Comprehensive loss
-
-89,113,000
-89,407,000
-60,829,000
Basic EPS
-1.03
-1.12
-1.27
-1.67
Diluted EPS
-1.03
-1.12
-1.27
-1.67
Basic Average Shares
93,166,571
79,507,474
71,259,239
36,033,045
Diluted Average Shares
93,166,571
79,507,474
71,259,239
36,033,045
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$96,207,000
(-8.28%↓ Y/Y)
Interest income
$14,591,000
(9.80%↑ Y/Y)
Loss before income
taxes
-$95,626,000
(-7.94%↓ Y/Y)
Income tax expense
$581,000
(123.46%↑ Y/Y)
Total other income,
net
$14,498,000
(9.19%↑ Y/Y)
Other expense, net
-$93,000
(-745.45%↓ Y/Y)
Loss from operations
-$110,124,000
(-8.10%↓ Y/Y)
Total operating
expenses
$110,124,000
(8.10%↑ Y/Y)
Research and development
$77,889,000
(11.09%↑ Y/Y)
General and
administrative
$32,235,000
(1.50%↑ Y/Y)
Buy us a coffee
Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN)